Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.47 |
| ▸ | SQLE | Q14534 | 5/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11548663 | 1.00 | KMT2A (0.52) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL20414120 | 1.00 | KMT2A (0.52) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL6820914 | 0.98 | KMT2A (0.55) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL6820912 | 0.98 | KMT2A (0.55) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL31632707 | 0.98 | KMT2A (0.54) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL20501916 | 0.98 | KMT2A (0.54) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL28149947 | 0.96 | KMT2A (0.57) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL25993302 | 0.86 | KMT2A (0.39) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL7285594 | 0.82 | KMT2A (0.56) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL11449012 | 0.82 | KMT2A (0.56) | KMT2AMEN1CYP3A4ALOX15MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109862787-A | Purposes of the cholesterol oxide sulfuric ester (OCS) in treatment inflammatory skin disease and skin lesion | 弗吉尼亚联邦大学 | 2019-06-07 | — | — | CN | disclosed |
| CN-109641030-A | METHODS AND COMPOSITIONS FOR MODULATING OPIOID WITHDRAWAL SYMPTOMS | 优特埃合伙有限公司 | 2019-04-16 | — | — | CN | disclosed |
| CN-106999446-A | Oxapigenin patch | 纽罗德姆有限公司 | 2017-08-01 | — | — | CN | disclosed |
| US-4139367-A | QUATERNARY AMMONIUM COMPOUNDS | HOFFMANN-LA ROCHE INC. (US) | 1979-02-13 | — | — | US | disclosed |
| US-4014678-A | 1-(3,7-Dimethyloctyl)-1(2-propenyl)-and 1(2-propynyl)-piperidinium bromides as plant growth regulants | HOFFMANN-LA ROCHE INC. (US) | 1977-03-29 | — | — | US | disclosed |